Sign in
4

Changes in Ownership

Tempest Therapeutics, Inc. Filed Acc 0001179110-16-029578

Chief Financial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Couturier Christophe · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-09-08 Grant or award : show line 1 in the form +50,000 50,600 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2016-09-08 Grant or award : show line 2 in the form Stock Option (right to buy) +200,000 200,000 D
Loading xslF345X03/edgar.xml…